Kopran Limited , a prominent pharmaceutical company, has recently witnessed a substantial change in its promoter group shareholding structure. The company has reported two significant off-market share transfer transactions among its promoter group members, resulting in a reshuffling of ownership within the group.

First Transaction: Complete Divestment by Three Promoters

In the first transaction, three promoter group members have completely divested their holdings in Kopran Limited:

1. Mridula Somani
2. Nupur Somani
3. Adarsh Somani

These individuals transferred a combined total of 12,39,650 shares, representing 2.57% of the company's total voting capital. The breakdown of their individual holdings prior to the transfer was as follows:

Following this transaction, the individual holdings of Mridula Somani, Nupur Somani, and Adarsh Somani have been reduced to zero.

Second Transaction: Divestment by Four Promoters

In a separate but related transaction, four other promoter group members also transferred their entire shareholdings:

1. Hridai Somani
2. Jaya Somani
3. Suhrid Somani
4. Susheel G Somani

These individuals collectively transferred 7,40,700 shares, accounting for 1.53% of the total voting capital. The individual holdings prior to the transfer were:

Similar to the first transaction, these promoters have also reduced their individual holdings to zero following the transfer.

Retained Shareholding

It's noteworthy that one promoter group member, Kumkum Somani, has retained a small stake in the company. Kumkum Somani continues to hold 35,635 shares, representing 0.07% of the total voting capital.

Impact on Company's Equity Share Capital

Despite these significant share transfers within the promoter group, Kopran Limited's equity share capital remains unchanged at INR 48.28 crores. This indicates that the transactions were internal transfers within the promoter group and did not involve any change in the company's overall capital structure.

Regulatory Compliance

The company has duly filed the required disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, informing both the National Stock Exchange and BSE Limited about these transactions.

These share transfers mark a significant change in the ownership structure within Kopran Limited's promoter group. While the reasons behind these transfers have not been disclosed, such movements often reflect strategic decisions or family wealth reorganization within promoter groups. Investors and market watchers will likely be keen to observe any potential impact on the company's governance or strategic direction following these changes in promoter shareholdings.

Kopran Limited, a prominent pharmaceutical company, has announced a significant development in its corporate structure. The co-promoters of the company have finalized a family agreement aimed at strengthening the management control of the organization.

Key Details of the Agreement

According to the disclosure made to the stock exchanges, the promoters of Kopran Limited have executed a Memorandum of Family Settlement (MOFS) dated September 1, 2025. This agreement is designed to address long-standing disputes related to shareholding and management rights in various listed and unlisted entities, including Kopran Limited.

Objectives of the Family Settlement

The primary objectives of the MOFS include:

• Resolving family disputes
• Settling inequalities in the partition of family businesses
• Preserving family property by avoiding litigation
• Maintaining the family's honor

Restructuring of Promoter Groups

As per the agreement, the promoters will be categorized into three distinct groups, each representing a branch of the Somani family:

1. The branch led by Mr. Susheel G. Somani
2. The branch comprising the lineal descendants of Late Mr. Rajendra Somani, headed by Mr. Adarsh Somani
3. The branch led by Mr. Surendra Somani

Impact on Management Control

The MOFS is expected to have a significant impact on the management and control of Kopran Limited. Previously, control was exercised jointly by promoters across multiple family branches. Following this agreement, management control will be consolidated and vested solely with the promoters of a single family branch acting together.

Share Transfer and Promoter Classification

The agreement outlines plans for inter-se transfer and purchase of shares among the family branches. Additionally, promoters within each group will be deemed as persons acting in concert. However, the three groups will not be regarded as acting in concert with each other, and their respective rights, obligations, and liabilities will remain separate.

Implications for Shareholders and Investors

While this agreement primarily affects the promoter group, it could have implications for the company's strategic direction and governance. Shareholders and investors should note that this restructuring aims to streamline decision-making processes and potentially lead to more efficient management of the company.

The execution of this family settlement marks a significant milestone in Kopran's corporate journey, potentially paving the way for more focused growth strategies and streamlined operations in the future.